Willow vs RxActivate: Oral GLP-1 with Tracking vs Gated Pricing
Quick verdict: Willow centers on an oral GLP-1 program with structured progress tracking and follow-up, starting at 299. RxActivate emphasizes clinician-matched GLP-1 plans but keeps pricing and plan details gated behind a two-minute eligibility questionnaire that requests contact information before revealing costs.
Explore Willow program details
Willow vs RxActivate: how they differ at a glance
This comparison focuses on the most distinctive differences supported by the sources: pricing transparency and gating, program structure and follow-up emphasis, eligibility and intake flow, regulatory and compounded medication notes, and documented service availability or verification steps.
1. Pricing transparency and gating
Willow lists a starting price of 299 and a price detail of 299 on its captured page. RxActivate does not display any price or billing terms before users complete the eligibility flow; pricing is unverified and only revealed after submission of name, email and phone number. If upfront pricing matters, Willow supplies a numeric starting figure while RxActivate requires contact information before revealing costs.
Check RxActivate eligibility flow
2. Program model and follow-up emphasis
Willow positions its offering as a telehealth-first weight management program built around oral GLP-1 plus wellness tracking and follow-up support. The source frames Willow as a structured journey to convert GLP-1 efficacy into sustainable outcomes through progress tracking and follow-up consultations. RxActivate is described as clinician-matched GLP-1 plans delivered through a clinician-reviewed online flow; its materials emphasize the eligibility questionnaire and matching but do not present the same progress-tracking claim captured for Willow.
View Willow follow-up and tracking
3. Intake, eligibility and state screening
RxActivate documents a two-minute eligibility questionnaire that requests goal, height, weight, target weight, timeline, medication history, sex assigned at birth, date of birth, state and safety screening. In a synthetic test, Alabama service availability was confirmed. Willow’s captured landing-page evidence was not readable, but its description emphasizes telehealth delivery and licensed clinicians determining medical appropriateness.
4. Regulatory notes and compounded medication status
Both sources include the same regulatory caution: treatment is available only when a licensed clinician determines it is medically appropriate. Each notes that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Willow explicitly states that compounded medications, when offered, are not FDA-approved. RxActivate repeats the regulatory note in its captured description.
5. Verifiable claims and captured evidence
RxActivate captured landing-page evidence and a functional eligibility flow in testing. It states 250,000+ members in the source. Willow’s page capture showed a browser error and reported no readable evidence captured for the landing page, though the site copy in the source includes its program positioning and features.
Comparison table: Willow vs RxActivate
| Criteria | Willow | RxActivate |
|---|---|---|
| Pricing visibility | Starting at 299 shown | Unverified; gated behind contact-info and questionnaire |
| Program focus | Oral GLP-1 with progress tracking and follow-up | Clinician-matched GLP-1 plans via eligibility flow |
| Intake flow | Telehealth-first; licensed clinician review when appropriate | Two-minute eligibility questionnaire; contact info required before price |
| Service verification | Landing page capture returned an error; captured evidence not readable | Landing-page evidence captured; Alabama serviceability confirmed in test |
| Regulatory note | Compounded meds not FDA-approved when offered | Compounded meds not FDA-approved when offered |
Start RxActivate eligibility quiz
How the differences affect your choice
If you prefer a clearly stated starting price and a program that emphasizes progress tracking and follow-up consultations, Willow is presented as a structured, telehealth-first weight management journey with a listed starting price of 299. If you prefer to be matched by a clinician after a detailed eligibility screening and are willing to submit contact information to learn pricing and plan specifics, RxActivate uses a gated two-minute questionnaire and clinician matching, with pricing unverified until after lead capture.
Final thoughts on Willow vs RxActivate
Willow vs RxActivate centers on pricing transparency and program model. Willow offers an oral GLP-1 program described with progress tracking and follow-up and shows a starting price of 299. RxActivate provides a clinician-matched model with a two-minute eligibility flow and confirmed intake behavior in testing, but it gates all pricing and plan details behind contact submission.
Learn more about Willow options
Choose Willow if you want a telehealth-first, structured weight management program that highlights progress tracking and follow-up and you value an explicitly stated starting price of 299. Choose RxActivate if you prefer clinician matching via a two-minute eligibility questionnaire and are prepared to provide contact information to see pricing, plan details and state availability.
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →